2025-03-11 05:58:30
Latest Post
NTPC Group to Invest Rs 96,000 Crore in Chhattisgarh
Arvind Fashions aims to expand its CLUB A stores across India
Somany Ceramics Elevates Luxury with the launch of Duragres 2025 Collection
Cosmo Films Bags SIES SOP Star Awards 2025 for Innovative Packaging Materials
Zaggle Prepaid Ocean Services Ltd receives 'Financial Institution of the Year' Award
Stock Report
SMS Lifesciences India Q3 FY2022 consolidated profit lower at Rs. 2.32 crores
Posted On : 2022-02-11 23:06:58( TIMEZONE : IST )
SMS Lifesciences India Limited has reported Consolidated financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 91.0939 crores during the period ended December 31, 2021 as compared to Rs. 87.4204 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 2.3291 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 10.2525 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 7.70 for the period ended December 31, 2021 as compared to Rs. 33.91 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 91.0939 crs | ₹87.4204 crs |  4.20% |
| Net Profit | ₹2.3291 crs | ₹10.2525 crs |  -77.28% |
| EPS | ₹7.70 | ₹33.91 | -77.29% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 91.0939 crores during the period ended December 31, 2021 as compared to Rs.67.1823 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.2.3291 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.2.6954 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.7.70 for the period ended December 31, 2021 as compared to Rs.8.92 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 91.0939 crs | ₹67.1823 crs | 35.59% |
| Net Profit | ₹2.3291 crs | ₹2.6954 crs | -13.59% |
| EPS | ₹7.70 | ₹8.92 | -13.68% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.254.4324 crores during the 9 Months period ended December 31, 2021 as compared to Rs.183.8329 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.16.2092 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.8.5030 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.53.61 for the 9 Months period ended December 31, 2021 as compared to Rs.28.13 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹254.4324 crs | ₹183.8329 crs | 38.40% |
| Net Profit | ₹16.2092 crs | ₹8.5030 crs | 90.63% |
| EPS | ₹53.61 | ₹28.13 | 90.58% |
Shares of SMS Lifesciences India Limited was last trading in BSE at Rs. 729.15 as compared to the previous close of Rs. 735.10. The total number of shares traded during the day was 420 in over 24 trades.
The stock hit an intraday high of Rs. 737.35 and intraday low of 729.05. The net turnover during the day was Rs. 306303.00.
